Novavax, Inc.
US ˙ NasdaqGS ˙ US6700024010

Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Margaret G Mcglynn. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Empresas com Posições Internas Reportadas

As declarações à SEC indicam que Margaret G Mcglynn reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
US:FOLD / Amicus Therapeutics, Inc. Director 0
US:NVAX / Novavax, Inc. Director 25,588
US:VRTX / Vertex Pharmaceuticals Incorporated Director 4,462
US:APD / Air Products and Chemicals, Inc. Director 42,814
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Margaret G Mcglynn. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Compras Internas NVAX / Novavax, Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em NVAX / Novavax, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

NVAX / Novavax, Inc. Insider Trades
Vendas Internas NVAX / Novavax, Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em NVAX / Novavax, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

NVAX / Novavax, Inc. Insider Trades
Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por Margaret G Mcglynn conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual
Preço
da Ação
Valor
da Transação
Valor
Restante
2026-04-27 2026-04-27 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
D - Sale to Issuer -94,631 0 -100.00 14.50 -1,372,150
2025-06-16 2025-06-12 4 NVAX NOVAVAX INC
Common Stock
M - Exercise 10,420 25,588 68.70
2025-06-06 2025-06-05 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 20,414 91,550 28.70
2025-02-05 2024-12-31 4 NVAX NOVAVAX INC
Common Stock
A - Award 1,178 15,168 8.42 8.61 10,143 130,596
2025-02-05 2024-09-30 4 NVAX NOVAVAX INC
Common Stock
A - Award 778 13,990 5.89 12.77 9,935 178,652
2025-02-05 2024-06-30 4 NVAX NOVAVAX INC
Common Stock
A - Award 713 13,212 5.70 13.93 9,932 184,043
2025-02-05 2024-03-31 4 NVAX NOVAVAX INC
Common Stock
A - Award 2,029 5,829 53.39 4.90 9,942 28,562
2024-06-14 2024-06-12 4 NVAX NOVAVAX INC
Common Stock
M - Exercise 6,670 10,470 175.53
2024-06-07 2024-06-06 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 11,847 71,136 19.98
2024-03-06 2024-03-05 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale -7,500 59,289 -11.23 13.40 -100,500 794,473
2024-03-06 2024-03-05 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
M - Exercise 7,500 66,789 12.65 2.80 21,000 187,009
2024-03-06 2024-03-04 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale -7,500 59,289 -11.23 13.29 -99,675 787,951
2024-03-06 2024-03-04 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
M - Exercise 7,500 66,789 12.65 2.80 21,000 187,009
2023-06-13 2023-06-10 4 NVAX NOVAVAX INC
Common Stock
M - Exercise 3,100 3,800 442.86
2023-06-12 2023-06-08 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 8,584 59,289 16.93
2023-01-17 2023-01-13 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale X -15,000 50,705 -22.83 13.03 -195,387 660,473
2023-01-17 2023-01-13 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
M - Exercise 15,000 65,705 29.58 3.32 49,800 218,141
2022-06-21 2022-06-17 4 NVAX NOVAVAX INC
Common Stock
M - Exercise 700 700
2022-06-10 2022-06-09 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 12,671 50,705 33.31
2022-05-04 2022-05-02 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
D - Sale to Issuer -15,000 0 -100.00
2022-05-04 2022-05-02 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale X -15,000 38,034 -28.28 6.99 -104,896 265,976
2022-05-04 2022-05-02 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
M - Exercise 15,000 53,034 39.44 4.79 71,850 254,033
2022-05-03 2022-05-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 4,462 4,462
2022-05-03 2022-05-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 921 5,609 19.65
2022-05-03 2022-05-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
D - Sale to Issuer -921 178 -83.80
2022-04-12 2022-04-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -5,000 5,000 -50.00
2022-04-12 2022-04-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -100 1,099 -8.34 281.49 -28,149 309,358
2022-04-12 2022-04-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4,900 1,199 -80.34 280.19 -1,372,931 335,948
2022-04-12 2022-04-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 5,000 6,099 454.96 127.54 637,700 777,866
2022-04-04 2022-03-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock (right to buy)
M - Exercise -5,000 10,000 -33.33 127.54 -637,700 1,275,400
2022-04-04 2022-03-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1,011 1,099 -47.91 262.97 -265,863 289,004
2022-04-04 2022-03-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2,970 2,110 -58.46 262.37 -779,239 553,601
2022-04-04 2022-03-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1,019 5,080 -16.71 261.28 -266,244 1,327,302
2022-04-04 2022-03-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 5,000 6,099 454.96 127.54 637,700 777,866
2022-02-01 2022-01-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -5,000 15,000 -25.00 127.54 -637,700 1,913,100
2022-02-01 2022-01-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -212 1,099 -16.17 243.24 -51,567 267,321
2022-02-01 2022-01-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2,087 1,311 -61.42 242.78 -506,682 318,285
2022-02-01 2022-01-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -800 3,398 -19.06 241.83 -193,464 821,738
2022-02-01 2022-01-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1,901 4,198 -31.17 240.53 -457,248 1,009,745
2022-02-01 2022-01-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 5,000 6,099 454.96 127.54 637,700 777,866
2021-06-22 2021-06-17 4 NVAX NOVAVAX INC
Restricted Stock Units
A - Award 700 700
2021-06-22 2021-06-17 4 NVAX NOVAVAX INC
Stock Option (Right to Buy)
A - Award 1,300 1,300
2021-06-14 2021-06-10 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
A - Award 36,111 36,111
2021-06-14 2021-06-10 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 10,115 38,034 36.23
2021-06-03 2021-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 699 4,688 17.52
2021-06-03 2021-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
D - Sale to Issuer -699 1,099 -38.88
2021-05-05 2021-05-03 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
M - Exercise -10,000 0 -100.00
2021-05-05 2021-05-03 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 27,919 -26.37 10.27 -102,704 286,739
2021-05-05 2021-05-03 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
M - Exercise 10,000 37,919 35.82 7.51 75,100 284,772
2021-05-04 2021-05-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 3,034 3,034
2021-05-04 2021-05-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 921 1,798 105.02
2020-12-09 2020-12-07 4 NVAX NOVAVAX INC
Stock Option (Right to buy)
A - Award 7,700 7,700
2020-10-01 2020-09-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 194 42,814 0.46 293.86 57,110 12,581,213
2020-08-26 2020-08-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
G - Gift -3,707 877 -80.87
2020-07-02 2020-06-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 238 42,619 0.56 238.61 56,791 10,169,388
2020-06-08 2020-06-04 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
A - Award 18,574 18,574
2020-06-08 2020-06-04 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 5,855 27,919 26.54
2020-06-03 2020-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 2,264 2,264
2020-06-03 2020-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 699 4,584 17.99
2020-04-20 2020-04-17 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
M - Exercise -10,000 0 -100.00
2020-04-20 2020-04-17 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 22,064 -31.19 11.00 -110,000 242,704
2020-04-20 2020-04-17 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
M - Exercise 10,000 32,064 45.32 2.81 28,100 90,100
2020-04-02 2020-03-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 237 42,381 0.56 206.53 48,888 8,753,005
2020-01-24 2020-01-23 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 630 42,145 1.52 238.04 150,000 10,032,093
2020-01-10 2020-01-09 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
M - Exercise -20,000 0 -100.00
2020-01-10 2020-01-09 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
S - Sale X -20,000 22,064 -47.55 10.00 -200,000 220,640
2020-01-10 2020-01-09 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
M - Exercise 20,000 42,064 90.65 3.32 66,400 139,652
2020-01-03 2019-12-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 204 41,514 0.49 235.33 47,921 9,769,589
2019-11-27 2019-11-26 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 3,973 41,311 10.64
2019-11-20 2019-11-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
G - Gift -239 3,885 -5.80
2019-10-24 2019-10-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -20,000 0 -100.00
2019-10-24 2019-10-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -20,000 4,124 -82.90 190.00 -3,800,000 783,560
2019-10-24 2019-10-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 20,000 24,124 484.97 72.14 1,442,800 1,740,305
2019-10-02 2019-09-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 199 37,246 0.54 221.86 44,255 8,263,348
2019-08-15 2019-08-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise 10,000 0 -100.00
2019-08-15 2019-08-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -10,000 4,124 -70.80 185.00 -1,850,000 762,940
2019-08-15 2019-08-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10,000 14,124 242.48 81.54 815,400 1,151,671
2019-07-02 2019-07-01 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 195 37,046 0.53 226.37 44,029 8,386,172
2019-07-01 2019-06-27 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
A - Award 19,473 19,473
2019-07-01 2019-06-27 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 6,250 22,064 39.52
2019-06-04 2019-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 1,801 3,989 82.31
2019-06-04 2019-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 6,659 6,659
2019-06-04 2019-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
D - Sale to Issuer -1,801 4,124 -30.40
2019-04-02 2019-04-01 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 217 36,852 0.59 186.51 40,532 6,873,230
2019-01-25 2019-01-24 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 952 36,634 2.67 157.71 150,140 5,777,625
2019-01-02 2018-12-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 256 35,682 0.72 156.92 40,250 5,599,296
2018-10-01 2018-09-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 236 35,426 0.67 167.80 39,669 5,944,481
2018-07-02 2018-06-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 254 35,190 0.73 155.16 39,390 5,460,015
2018-06-11 2018-06-07 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 8,912 8,912
2018-06-11 2018-06-07 4 FOLD AMICUS THERAPEUTICS INC
Common Stock
A - Award 3,081 8,895 52.99
2018-06-05 2018-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Deferred Stock Units
A - Award 2,188 2,188
2018-06-05 2018-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 3,229 3,229
2018-06-05 2018-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
D - Sale to Issuer -2,188 5,925 -26.97
2018-06-05 2018-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 1,801 8,113 28.53
2018-05-18 2018-05-16 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
M - Exercise -10,000 20,000 -33.33
2018-05-18 2018-05-16 4 FOLD AMICUS THERAPEUTICS INC
Common Stock
S - Sale X -10,000 15,814 -38.74 16.00 -160,000 253,024
2018-05-18 2018-05-16 4 FOLD AMICUS THERAPEUTICS INC
Common Stock
M - Exercise 10,000 25,814 63.24 3.32 33,200 85,702
2018-04-03 2018-03-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 208 34,936 0.60 158.18 32,972 5,526,131
2018-03-05 2018-03-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -10,000 10,000 -50.00
2018-03-05 2018-03-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -10,000 6,312 -61.30 170.00 -1,700,000 1,073,040
2018-03-05 2018-03-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10,000 16,312 158.43 81.54 815,400 1,330,080
2018-01-29 2018-01-25 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 863 34,727 2.55 174.00 150,162 6,042,545
2018-01-24 2018-01-23 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -10,000 0 -100.00
2018-01-24 2018-01-23 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -10,000 6,217 -61.66 165.00 -1,650,000 1,025,805
2018-01-24 2018-01-23 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10,000 16,217 160.85 59.55 595,500 965,722
2018-01-24 2018-01-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -10,000 10,000 -50.00
2018-01-24 2018-01-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -10,000 6,217 -61.66 160.00 -1,600,000 994,720
2018-01-24 2018-01-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10,000 16,217 160.85 59.55 595,500 965,722
2018-01-02 2017-12-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 200 33,864 0.59 163.67 32,781 5,542,565
2017-10-02 2017-09-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 215 33,664 0.64 151.32 32,577 5,094,033
2017-07-05 2017-06-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 223 33,449 0.67 144.84 32,365 4,844,709
2017-06-16 2017-06-13 4/A FOLD AMICUS THERAPEUTICS INC
Common Stock
A - Award 5,814 15,814 58.14
2017-06-15 2017-06-13 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 16,236 16,236
2017-06-15 2017-06-13 4 FOLD AMICUS THERAPEUTICS INC
Common Stock
A - Award 5,814 5,814
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise 5,295 5,295
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 2,188 6,217 54.31
2017-04-04 2017-03-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 203 33,225 0.61 136.78 27,706 4,544,549
2017-01-27 2017-01-26 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 807 33,023 2.50 148.81 120,090 4,914,106
2017-01-04 2016-12-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 190 32,216 0.59 145.12 27,542 4,675,141
2016-09-30 2016-09-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 183 32,026 0.57 149.78 27,385 4,796,839
2016-07-05 2016-06-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 199 31,843 0.63 136.55 27,180 4,348,170
2016-06-13 2016-06-09 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 20,000 20,000
2016-06-03 2016-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 7,073 7,073
2016-06-03 2016-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 2,941 4,029 270.31 0.01 29 40
2016-04-25 2016-03-31 4/A APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 170 31,644 0.54 145.03 24,677 4,589,331
2016-03-31 2016-03-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 343 31,816 1.09 145.03 49,677 4,614,331
2016-01-29 2016-01-28 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 1,009 31,474 3.31 119.01 120,081 3,745,705
2016-01-05 2015-12-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 401 30,465 1.33 133.20 53,352 4,057,920
2015-11-20 2015-11-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -12,500 0 -100.00
2015-11-20 2015-11-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -12,500 1,088 -91.99 130.15 -1,626,875 141,603
2015-11-20 2015-11-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 12,500 13,588 1,148.90 57.27 715,875 778,185
2015-11-10 2015-11-10 4 FOLD AMICUS THERAPEUTICS INC
Common Stock
P - Purchase 10,000 10,000 10.27 102,657 102,657
2015-09-30 2015-09-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 439 30,064 1.48 125.25 54,996 3,765,557
2015-08-05 2015-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise 12,500 12,500
2015-08-05 2015-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -100 1,088 -8.42 138.98 -13,898 151,210
2015-08-05 2015-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2,700 1,188 -69.44 138.22 -373,194 164,205
2015-08-05 2015-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -6,500 3,888 -62.57 137.26 -892,190 533,667
2015-08-05 2015-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3,200 10,388 -23.55 136.49 -436,768 1,417,858
2015-08-05 2015-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 12,500 13,588 1,148.90 57.27 715,875 778,185
2015-06-30 2015-06-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 388 29,625 1.33 142.08 55,182 4,209,153
2015-06-12 2015-06-10 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 20,000 20,000
2015-06-03 2015-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise 7,500 0 -100.00
2015-06-03 2015-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise 5,000 25,000 25.00
2015-06-03 2015-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 20,000 20,000
2015-06-03 2015-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -9,020 1,088 -89.24 127.53 -1,150,321 138,753
2015-06-03 2015-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3,480 10,108 -25.61 126.78 -441,194 1,281,492
2015-06-03 2015-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 7,500 13,588 123.19 53.85 403,875 731,714
2015-06-03 2015-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 5,000 6,088 459.56 57.27 286,350 348,660
2015-04-08 2015-04-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 12,500 7,500 -250.00
2015-04-08 2015-04-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -400 1,088 -26.88 119.78 -47,912 130,321
2015-04-08 2015-04-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3,900 1,488 -72.38 118.97 -463,983 177,027
2015-04-08 2015-04-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -6,000 5,388 -52.69 118.32 -709,920 637,508
2015-04-08 2015-04-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2,200 11,388 -16.19 117.14 -257,708 1,333,990
2015-04-08 2015-04-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 12,500 13,588 1,148.90 53.85 673,125 731,714
2015-03-31 2015-03-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 369 29,237 1.28 152.75 56,338 4,465,928
2015-02-13 2012-08-10 5 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 15 1,088 1.40 51.23 768 55,738
2015-02-13 2011-12-07 5 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 9 1,088 0.83 29.19 263 31,759
2015-02-13 2011-12-06 5 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 33 1,088 3.13 29.66 979 32,270
2015-02-13 2011-11-22 5 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 31 1,088 2.93 28.00 868 30,464
2015-01-23 2015-01-22 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 832 28,868 2.97 144.32 120,074 4,166,233
2015-01-05 2014-12-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 353 28,036 1.27 147.57 52,066 4,137,276
2014-09-30 2014-09-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 414 27,683 1.52 134.77 55,748 3,730,865
2014-06-30 2014-06-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 415 27,270 1.54 128.83 53,428 3,513,136
2014-06-16 2014-06-12 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 15,000 15,000
2014-06-03 2014-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 20,000 20,000
2014-04-01 2014-03-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 445 26,855 1.69 118.44 52,733 3,180,686
2014-01-24 2014-01-23 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 1,081 26,410 4.27 111.01 120,002 2,931,730
2014-01-03 2013-12-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 452 25,329 1.82 113.43 51,326 2,873,023
2013-09-30 2013-09-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 465 24,876 1.91 109.78 51,082 2,730,899
2013-07-01 2013-06-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 445 24,411 1.86 96.13 42,766 2,346,610
2013-06-17 2013-06-13 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 15,000 15,000
2013-06-04 2013-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 20,000 20,000
2013-04-01 2013-03-29 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 486 23,966 2.07 86.28 41,906 2,067,780
2013-01-25 2013-01-24 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 1,361 23,480 6.15 88.23 120,081 2,071,660
2013-01-02 2012-12-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 483 22,119 2.23 84.80 40,955 1,875,710
2012-11-08 2012-11-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 1,000 1,000 45.50 45,500 45,500
2012-10-01 2012-09-28 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 496 21,636 2.35 83.18 41,280 1,799,704
2012-07-02 2012-06-29 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 509 21,140 2.47 76.56 38,954 1,618,478
2012-06-15 2012-06-13 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 15,000 15,000
2012-06-01 2012-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 20,000 20,000
2012-03-30 2012-03-30 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 458 20,631 2.27 90.49 41,411 1,866,917
2012-01-27 2012-01-26 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 1,362 20,174 7.24 88.16 120,074 1,778,501
2012-01-04 2011-12-31 4 APD AIR PRODUCTS & CHEMICALS INC /DE/
Phantom Stock
A - Award 408 18,812 2.22 84.98 34,674 1,598,607
2011-05-13 3 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
0
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)